Lupin Builds Momentum As It Anticipates FDA Action On Spiriva Rival
Recent Boosts Also Include EIR For Nagpur Plant As Well As US Lurasidone Launch
• By David Wallace
Action on Lupin’s Spiriva generic is expected to add to US momentum • Source: Shutterstock 
